In Alzheimer’s and Parkinson’s diseases, the levels of brain-derived neurotrophic factor (BDNF), synaptophysin (SYN), and nerve growth factor (NGF) are reduced, leading to impaired synaptic plasticity as well as decreased neuronal density and cholinergic neuron survival in the hippocampus [38]. Here, NGF is linked to Parkinson disease.